Sessions:
2026 年 2 月 12 日 – 10:00-11:00am JST
2026 年 4 月 28 日 – 10:00-11:00am EST/3:00-4:00pm GMT
Services: QSP Consulting Service
产品： Certara IQ™
概述
Certara IQ™ is the industry-leading AI-powered Quantitative Systems Pharmacology (QSP) modeling platform, transforming drug development by making QSP modeling accessible, scalable, and predictive for organizations worldwide. By combining AI-driven modeling, cloud computing, and pre-validated model libraries, it delivers high-confidence predictions—accelerating decision-making across the entire drug development pipeline.
Why attend?
Get an exclusive look at how Certara IQ is reshaping drug discovery and development, bringing QSP modeling to the forefront of precision medicine. Learn how this cutting-edge platform is already powering hundreds of research projects and regulatory submissions, making complex modeling more accessible, efficient, and actionable.
Key takeaways
- AI + Cloud-Powered QSP: See how Certara IQ integrates AI and cloud computing to run faster simulations and generate reliable insights.
- Pre-Validated Model Libraries: Certara IQ includes a repository of validated, well-documented models across therapeutic areas. These models provide powerful starting points for new projects, reducing duplication and accelerating timelines.
- User-Friendly Collaboration: Discover the platform’s intuitive interface, designed to reduce programming barriers and enhance team efficiency.
- Live Expert Insights: Hear from Josh Apgar, Certara’s QSP expert, and participate in a live Q&A to get your questions answered.
点击报名
Joshua Apgar, PhD
VP, Head of QSP Software在共同创办Applied BioMath公司之前，Joshua 是勃林格殷格翰制药公司免疫学和炎症部系统生物学小组的首席科学家。他的工作是利用基于物理学的模型：转化体外和体内数据、评估靶点可行性、了解药物作用机制并预测人体剂量。这项工作的最终目标是通过对药物药理学和疾病病理生理学的深入定量研究，减少药物开发后期的损耗。
Joshua 在麻省理工学院获得生物工程博士学位，在那里他从事系统生物学的实验设计工作，研究重点是识别可以用于估算未知参数并揭示信号转导网络复杂机制的可操作性实验。在此之前，Joshua 在 Avaki开发了一个可扩展性极强的软件平台，以支持生命科学和工程领域的高性能计算和企业信息集成。
点击报名
